ArticleInfluenza and other respiratory viruses2026
Genomic Surveillance of SARS-CoV-2 in Senegal (2020-2024): Variant Turnover, Omicron Introductions, and Interregional Spread.
Article in Influenza and other respiratory viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
backgroundGenomic surveillance is central to tracking SARS-CoV-2 evolution, variant replacement, and transmission dynamics. In Senegal, the Institut Pasteur de Dakar generated one of the largest national longitudinal SARS-CoV-2 genomic datasets, offering a unique view of viral spread from the first pandemic wave to the post-Omicron period.
aimsThis study aimed to reconstruct SARS-CoV-2 evolution and dissemination in Senegal from March 2020 to September 2024, assess variant and Omicron sublineage dynamics, infer introduction and interregional spread patterns, and describe the national mutational landscape. MATERIAL AND
methodsA total of 4820 SARS-CoV-2 genomes generated by the Institut Pasteur de Dakar were analyzed. Lineage assignment, temporal and regional distribution, time-scaled phylogenetics, discrete phylogeographic reconstruction, and mutation profiling were used to assess variant turnover, international seeding, intranational dissemination, and genomic diversification.
resultsAncestral A/B lineages predominated in 2020 before replacement by Alpha and Beta in early 2021, followed by Delta in mid-2021, which coincided with the highest case burden. From late 2021, Omicron became dominant, with rapid turnover of BA.1/BA.2, BA.4/BA.5, BQ.1.1, XBB, and BA.2.86, while later waves were smaller. Dakar contributed 64.7% of genomes and emerged as the main hub for inferred introductions and interregional spread, with Kaolack and Diourbel as secondary hubs. Major Omicron sublineages resulted from multiple introductions, mainly from Africa and Europe, with BA.1/BA.2 seeded from a broader range of continents than later lineages. Mutation profiling showed strong enrichment in Spike, with recurrent changes in ORF1a/ORF1b and nucleocapsid. DISCUSSION: The findings reveal repeated variant replacement, shifting international seeding routes, and a hub-and-spoke pattern of national dissemination centered on Dakar. Declining later waves may reflect increasing hybrid population immunity, although interpretation remains influenced by heterogeneous sequencing intensity.
conclusionsThis study provides an integrated national picture of SARS-CoV-2 evolution in Senegal and supports decentralized sequencing, stronger metadata capture, and routine use of genomic evidence for public health decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.